BIOMAT Database Logo BIOMAT Database Logo

Gamma knife radiosurgery for malignant melanoma brain metastases. 1998

S K Seung, and P K Sneed, and M W McDermott, and H K Shu, and S P Leong, and S Chang, and P L Petti, and V Smith, and L J Verhey, and W M Wara, and T L Phillips, and D A Larson
Department of Radiation Oncology, University of California, San Francisco 94143-0226, USA.

OBJECTIVE To evaluate the efficacy and toxicity of gamma knife radiosurgery in the treatment of melanoma metastases to the brain. METHODS We retrospectively reviewed 55 patients with single or multiple intracranial melanoma metastases treated at the University of California, San Francisco, with gamma knife radiosurgery from 1991 through 1995. Sixteen patients were treated with gamma knife radiosurgery for recurrence following previous radiation therapy, 11 received radiosurgery as a boost to whole-brain radiation therapy, and 28 had radiosurgery alone for initial management of brain metastases. The median minimum radiosurgery tumor dose for 140 treated lesions was 19 Gy (range, 10-22 Gy) prescribed at the 35% to 90% isodose contour (median, 50%). The median total target volume per patient was 6.1 cc (range, 0.25-28.3 cc). RESULTS With a median follow-up of 75 weeks in living patients, the median survival times were 35 weeks overall: 35 weeks for patients with solitary metastases versus 33 weeks for those with multiple metastases. A factor that was significant in univariate analysis of survival was total target volume treated. This parameter remained significant on multivariate analysis. The actuarial median freedom from progression analyzed by lesion for 113 lesions in 46 patients with imaging follow-up was 89 weeks with 6-month and 1-year actuarial freedom from progression rates of 89% (95% confidence interval, 80%-95%) and 77% (95% confidence interval, 62%-87%). In univariate analysis, improved freedom from progression was associated with smaller target volume treated, smaller maximum diameter, or higher prescribed dose. Four patients (7%) developed acute Radiation Therapy Oncology Group grade > or = 2 morbidity, and five patients (9%) developed late grade > or = 2 morbidity. CONCLUSIONS Median survival and freedom from progression in patients treated with radiosurgery for melanoma metastatic to the brain are comparable to results in published radiosurgery series of grouped histologies. For melanoma patients, total intracranial tumor volume appears to be of greater prognostic significance than the absolute number of metastases treated. We conclude that gamma knife radiosurgery is effective and should be considered among various management strategies.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

S K Seung, and P K Sneed, and M W McDermott, and H K Shu, and S P Leong, and S Chang, and P L Petti, and V Smith, and L J Verhey, and W M Wara, and T L Phillips, and D A Larson
Gamma knife radiosurgery for malignant melanoma brain metastases.
January 2007, Clinical neurosurgery,
S K Seung, and P K Sneed, and M W McDermott, and H K Shu, and S P Leong, and S Chang, and P L Petti, and V Smith, and L J Verhey, and W M Wara, and T L Phillips, and D A Larson
Gamma knife radiosurgery in the management of malignant melanoma brain metastases.
March 2007, Neurosurgery,
S K Seung, and P K Sneed, and M W McDermott, and H K Shu, and S P Leong, and S Chang, and P L Petti, and V Smith, and L J Verhey, and W M Wara, and T L Phillips, and D A Larson
[Gamma knife radiosurgery for brain metastases].
December 2002, No to shinkei = Brain and nerve,
S K Seung, and P K Sneed, and M W McDermott, and H K Shu, and S P Leong, and S Chang, and P L Petti, and V Smith, and L J Verhey, and W M Wara, and T L Phillips, and D A Larson
Outcomes in patients treated with gamma knife radiosurgery for brain metastases from malignant melanoma.
June 1998, Neurosurgical focus,
S K Seung, and P K Sneed, and M W McDermott, and H K Shu, and S P Leong, and S Chang, and P L Petti, and V Smith, and L J Verhey, and W M Wara, and T L Phillips, and D A Larson
Gamma Knife radiosurgery for cystic brain metastases.
January 2016, British journal of neurosurgery,
S K Seung, and P K Sneed, and M W McDermott, and H K Shu, and S P Leong, and S Chang, and P L Petti, and V Smith, and L J Verhey, and W M Wara, and T L Phillips, and D A Larson
[Analysis of results of Gamma Knife radiosurgery for patients with melanoma brain metastases].
January 2015, Voprosy onkologii,
S K Seung, and P K Sneed, and M W McDermott, and H K Shu, and S P Leong, and S Chang, and P L Petti, and V Smith, and L J Verhey, and W M Wara, and T L Phillips, and D A Larson
Gamma Knife radiosurgery for brain metastases from gastrointestinal primary.
August 2017, Journal of medical imaging and radiation oncology,
S K Seung, and P K Sneed, and M W McDermott, and H K Shu, and S P Leong, and S Chang, and P L Petti, and V Smith, and L J Verhey, and W M Wara, and T L Phillips, and D A Larson
Gamma knife radiosurgery for brain metastases from breast cancer.
November 2013, Journal of Korean Neurosurgical Society,
S K Seung, and P K Sneed, and M W McDermott, and H K Shu, and S P Leong, and S Chang, and P L Petti, and V Smith, and L J Verhey, and W M Wara, and T L Phillips, and D A Larson
Gamma knife radiosurgery for ten or more brain metastases.
December 2008, Journal of Korean Neurosurgical Society,
S K Seung, and P K Sneed, and M W McDermott, and H K Shu, and S P Leong, and S Chang, and P L Petti, and V Smith, and L J Verhey, and W M Wara, and T L Phillips, and D A Larson
Gamma knife radiosurgery for renal cell carcinoma brain metastases.
December 2002, Journal of neurosurgery,
Copied contents to your clipboard!